Gladstone Institutional Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Buy |
25,488
+14,106
| +124% | +$973K | 0.07% | 257 |
|
|
2025
Q1 | $771K | Sell |
11,382
-1,443
| -11% | -$97.8K | 0.04% | 378 |
|
|
2024
Q4 | $576K | Sell |
12,825
-1,731
| -12% | -$77.7K | 0.03% | 442 |
|
|
2024
Q3 | $915K | Buy |
14,556
+2,832
| +24% | +$178K | 0.04% | 335 |
|
|
2024
Q2 | $692K | Sell |
11,724
-44
| -0.4% | -$2.6K | 0.04% | 367 |
|
|
2024
Q1 | $939K | Sell |
11,768
-1,477
| -11% | -$118K | 0.05% | 294 |
|
|
2023
Q4 | $1.05M | Sell |
13,245
-661
| -5% | -$52.2K | 0.06% | 280 |
|
|
2023
Q3 | $971K | Buy |
13,906
+1,348
| +11% | +$94.1K | 0.06% | 270 |
|
|
2023
Q2 | $868K | Buy |
12,558
+3,056
| +32% | +$211K | 0.05% | 301 |
|
|
2023
Q1 | $706K | Buy |
9,502
+293
| +3% | +$21.8K | 0.05% | 346 |
|
|
2022
Q4 | $858K | Buy |
9,209
+238
| +3% | +$22.2K | 0.06% | 303 |
|
|
2022
Q3 | $856K | Sell |
8,971
-8,250
| -48% | -$787K | 0.07% | 297 |
|
|
2022
Q2 | $1.6M | Sell |
17,221
-7,421
| -30% | -$688K | 0.13% | 186 |
|
|
2022
Q1 | $2.49M | Buy |
24,642
+387
| +2% | +$39.2K | 0.17% | 159 |
|
|
2021
Q4 | $2.5M | Buy |
24,255
+18,502
| +322% | +$1.91M | 0.19% | 144 |
|
|
2021
Q3 | $488K | Sell |
5,753
-3,342
| -37% | -$283K | 0.05% | 330 |
|
|
2021
Q2 | $759K | Buy |
9,095
+4,089
| +82% | +$341K | 0.09% | 229 |
|
|
2021
Q1 | $377K | Buy |
+5,006
| New | +$377K | 0.06% | 282 |
|